Marketing-authorisation holder
Diurnal Europe B.V.
7 medicines in 2 countries, as authorisation holder and marketer.
Medicines
Every medicine in the registers under its name, current ones first.
7 medicines
| Medicine | Substance | Country | Status | Authorised |
|---|---|---|---|---|
| ALKINDI 0,5 MG GRANULADO EN CAPSULAS PARA ABRIR0,5 mg · Granulado en capsulas para abrir | Hydrocortisone | Spain | Authorised | 2020 |
| ALKINDI 1 MG GRANULADO EN CAPSULAS PARA ABRIR1 mg · Granulado en capsulas para abrir | Hydrocortisone | Spain | Authorised | 2020 |
| ALKINDI 2 MG GRANULADO EN CAPSULAS PARA ABRIR2 mg · Granulado en capsulas para abrir | Hydrocortisone | Spain | Authorised | 2020 |
| ALKINDI 5 MG GRANULADO EN CAPSULAS PARA ABRIR5 mg · Granulado en capsulas para abrir | Hydrocortisone | Spain | Authorised | 2020 |
| EFMODY 10 MG CAPSULAS DURAS DE LIBERACION MODIFICADA10 mg · Cápsula dura de liberación modificada | Hydrocortisone | Spain | Authorised | 2021 |
| Efmody 20 mg, harde capsulesCapsule, hard | Hydrocortisone | Netherlands | Authorised | 2021 |
| EFMODY 5 MG CAPSULAS DURAS DE LIBERACION MODIFICADA5 mg · Cápsula dura de liberación modificada | Hydrocortisone | Spain | Authorised | 2021 |
Countries
Where it holds or makes medicines, with how many are current.
| Country | Medicines | Current | Past | Companies |
|---|---|---|---|---|
| Spain | 6 | 6 | 0 | CompaniesAll medicines |
| Netherlands | 1 | 1 | 0 | CompaniesAll medicines |
Therapeutic areas
The ATC groups most of its medicines belong to, largest first.
- Corticosteroids for systemic useSystemic hormonal preparations · ATC H02A
Top substances
The active substances in most of its medicines.
Names in the registers
How the registers spell it, normalised: legal forms, accents and capitals removed.
- diurnal europe
- diurnal europe b v
Sources and licences
Compiled by Prognia from the public medicine and company registers below. Logos are not used.
Fuente de la información: AEMPS (CIMA).
Licence: AEMPS open data reuse with attribution
Fuente de la información: Agencia Española de Medicamentos y Productos Sanitarios www.aemps.gob.es; CIMA presentaciones, acquired 11 October 2026 UTC; each source response/update date retained.
Licence: AEMPS explicit public open-data reuse for citizens and companies; source attribution and update date required
Fuente de la información: Agencia Española de Medicamentos y Productos Sanitarios www.aemps.gob.es; CIMA medicamentos, acquired 11 October 2026 UTC; each source response/update date retained.
Licence: AEMPS explicit public open-data reuse for citizens and companies; source attribution and update date required
College ter Beoordeling van Geneesmiddelen, Geneesmiddeleninformatiebank metadata, source update 07-10-2026; downloaded 08-10-2026; factual adaptation.
Licence: Conditional noncreative administrative factual metadata; no dataset-wide CC0 claim
Report an error or request removalCorrections from the company itself are welcome.
At a glance
- Type
- Marketing-authorisation holder
- Medicines
- 7
- Countries
- 2
- Roles
- Authorisation holder and marketer